Achieving Localised Delivery With Magnetic Vectoring - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Achieving Localised Delivery With Magnetic Vectoring
Charles E. Seeney tells us about the possibilities of nanotechnology and magnetism, and how a novel approach could improve localised drug delivery.


Pharmaceutical Technology Europe


References

1. Magnetism in Medicine: A Handbook, Wilfried Andrä and Hannes Nowak, Eds. (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2nd ed., 2007).

2. M.N. Faddis et al., Circulation 106(23), 2980–2985 (2002).

3. M. Baumann et al., Rofo 178(9), 911–917 (2006).

4. J. Klostergaard et al, Future Medicines: Nanomedicine (In press, 2012).

5. R. Bawa, Nanotechnology Law and Business 5, 135–155 (2008).

6. S. Laurent S and M. Mahmoudi, Int. J. Mol. Epidemiol. Genet. 2(4), 367–390 (2011).

7. J. Klostergaard et al., AIP Conference Proceedings (Germany, 2010) pp. 382–387

8. J. Klostergaard et al., J. Magnetism Magnetic Materials 311(1) (2007).

9. C. Plank et al., Expert Opin. Biol. Ther. 3(5), 745–758 (2003).

10. M. Johannsen et al., Int. J. Hyperthermia 21(7), 637–747 (2005).

11. C.E. Seeney et al., Biomaterials, 26(14), (2005).

12. P.Y. Chen et al., Neuro Oncol. 12(10), 1050–60 (2010).

13. M.Y. Hua et al., Biomaterials 32(2), 516–27 (2011).

14. G. Lian et al., Microsc Microanal 10, Suppl. 2 (2004).

15. M. Ma, A: Physicochem. Eng. Aspects 212, 219–226 (2003).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology Europe,
Click here